Diagnostic accuracy study of automated stratification of Alzheimer’s disease and mild cognitive impairment via deep learning based on MRI
Xiaowen Chen, Mingyue Tang, Aimin Liu, Xiao‐Qin Wei
Abstract
Background: Alzheimer's disease (AD) is a widespread neurodegenerative disease that mostly affects the elderly population. Given its prevalence, a precise and efficient stratification system based on AD symptomology that uses functional magnetic resonance imaging (MRI) has great potential in the clinical diagnosis and prognosis estimation of AD patients. It was evident that deep learning methods have performed extremely well in the field of automated stratification of AD based on MRI because of their high predicting accuracy and reliability. Methods: We proposed a deep convolutional neural network (CNN) and iterated random forest (RF) architecture for MRI image stratification by both anatomical location and image modality using the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. We employed 3 cross-sectional data sets from the ADNI to conduct our binary-stratification [AD and normal controls (NCs), or AD and mild cognitive impairment (MCI)], and multi-stratification (AD, MCI, and NCs) process using MRI. And the accuracy, recall, specificity, area under the curve of receiver operating characteristic curve (AUC), F1 and Matthew's correlation coefficient (MCC) scores to assess accuracy of auxiliary clinical diagnoses. Results: NC, the mean training AUC of the 3 runs was 90.6% in 95% CIs. In terms of the 3 stratifications of AD, MCI, and NC, relative precision, recall, and specificity for each category in the training test (TS) were all near 89%, while the F1 and MCC scores of both sets were 59.9% and 59.5%, respectively. Conclusions: Using a deep CNN and iterated RF architecture, we showed that brain image stratification is a promising means for evaluating AD, and examining the underlying etiology of the disease, by applying computer and medical images to achieve the early auxiliary diagnosis of AD. However, we still have a long way to go from the discovery of image markers to clinical application.